Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Nerve Block for Painful Hypertensive Leg Ulcer
NCT01964911Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Feb 2014
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in Martorell hypertensive ischemic leg ulcer (HLU), sponsored by CHU de Nantes. Started Feb 2014; status: completed.
02
Drugs
ropivacaine
03
Conditions
Martorell hypertensive ischemic leg ulcer (HLU)
Beyond the preview
Go deeper on NCT01964911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964911.